Shabir Madhi to Viral Vaccines
This is a "connection" page, showing publications Shabir Madhi has written about Viral Vaccines.
Connection Strength
1,684
-
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial. Lancet HIV. 2022 05; 9(5):e309-e322.
Score: 0,768
-
WHO guidelines for treatment of severe pneumonia. Lancet. 2007 Aug 04; 370(9585):386-7.
Score: 0,276
-
Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers. Vaccine. 2006 Mar 20; 24(13):2432-9.
Score: 0,247
-
AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2. BMC Med. 2022 03 28; 20(1):128.
Score: 0,191
-
COVID-19 vaccines and neglected pregnancy. Lancet. 2020 09 05; 396(10252):e22.
Score: 0,171
-
Acute viral bronchiolitis in South Africa: Strategies for management and prevention. S Afr Med J. 2016 Apr; 106(4):27-9.
Score: 0,031